STAGE IIIC BREAST CANCER
Clinical trials for STAGE IIIC BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIC BREAST CANCER trials appear
Sign up with your email to follow new studies for STAGE IIIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo tested to shrink breast tumors before surgery
Disease control OngoingThis study tested whether adding the drug trastuzumab to standard chemotherapy before surgery helps shrink breast tumors more effectively. It involved 92 women with early-stage breast cancer who had not received prior treatment. The main goals were to see if the combination was s…
Matched conditions: STAGE IIIC BREAST CANCER
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Apr 04, 2026 01:50 UTC
-
New chemo combo aims to shrink tough breast tumors before surgery
Disease control OngoingThis study tested whether giving two chemotherapy drugs (carboplatin and nab-paclitaxel) before surgery could effectively shrink tumors in patients with a hard-to-treat type of breast cancer called triple-negative breast cancer. The goal was to see if this approach could complete…
Matched conditions: STAGE IIIC BREAST CANCER
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Early trial tests experimental vaccine for Tough-to-Treat breast cancer
Disease control OngoingThis early-stage study is testing the safety and immune response of a new vaccine called STEMVAC in patients with advanced HER2-negative breast cancer. The vaccine aims to train the body's immune system to recognize and attack cancer cells, particularly those that are resistant t…
Matched conditions: STAGE IIIC BREAST CANCER
Phase: PHASE1 • Sponsor: University of Washington • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for tough breast cancer: trial tests Post-Surgery drug options
Disease control OngoingThis study is for patients with a specific, aggressive type of breast cancer (triple-negative, basal-like) where cancer cells remain after initial chemotherapy and surgery. It aims to find out which of two follow-up chemotherapy drugs—platinum-based drugs (cisplatin/carboplatin) …
Matched conditions: STAGE IIIC BREAST CANCER
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hormone therapy combinations tested to shrink breast tumors before surgery
Disease control OngoingThis large study compares different hormone therapy approaches given before surgery to shrink breast cancer tumors in postmenopausal women. Researchers are testing whether newer drug combinations work better than the current standard treatment at controlling cancer growth and pre…
Matched conditions: STAGE IIIC BREAST CANCER
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
New scan could tell doctors if breast cancer drugs will work before starting treatment
Diagnosis OngoingThis study is testing a special PET scan to see if it can predict how well a patient's HER2-positive breast cancer will respond to two targeted drugs (trastuzumab and pertuzumab) given before surgery. Researchers will give 18 women with locally advanced breast cancer a scan using…
Matched conditions: STAGE IIIC BREAST CANCER
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Apr 04, 2026 01:50 UTC